Status: Finalised First registered on: 23/05/2016
Last updated on: 16/01/2020
1. Study identification
EU PAS Register NumberEUPAS13470
Official titleBeyond Pooled –Part of the BEYOND study program (BEnefit of NOACs studY of nOn-valvular AF patieNts in NorDic countries)
Study title acronymBEYOND Pooled (Denmark, Norway, Sweden)
Study typeObservational study
Brief description of the studyThe overall aim of this study is to evaluate effectiveness and safety of each NOAC compared with warfarin in treatment-naïve initiators of anticoagulants with NVAF in routine clinical practice in Denmark, Norway and Sweden. The study will use pooled data from nationwide registries in Denmark, Norway and Sweden.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicableCCTR protocol number: B0661103
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsAarhus University Dept. of Clinical Epidemiology
Department/Research groupAarhus University, Department of Clinical Epidemiology
Organisation/affiliationAarhus University / Aarhus University Hospital
Website/Homepagewww.kea.au.dk
Details of (Primary) lead investigator
Title Professor
Last name Ehrenstein
First name Vera
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Multiple centres

In total how many centres are involved in this Study?3
Department of Clinical Epidemiology, Olof Palmes Allé 43-45
Department of Global Public Health and Primary Care, Kalfarveien 31, NO-5018 Bergen, Norway
Centre for Pharmacoepidemiology, Karolinska Universitetssjukhuset Solna,
Countries in which this study is being conducted
International study

Denmark
Norway
Sweden
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed15/12/2015
Start date of data collection01/10/201717/08/2018
Start date of data analysis22/11/201830/11/2018
Date of interim report, if expected
Date of final study report31/08/201929/07/2019
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesPfizer, Inc.100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Jenkins
First name Aaron
Address line 1Walton Oaks, Dorking Road
Address line 2 
Address line 3 
CityTadworth, Surrey 
PostcodeKT20 7NS 
CountryUnited Kingdom
Phone number (incl. country code)441737330722 
Alternative phone number 
Fax number (incl. country code) 
Email address Aaron.Jenkins@pfizer.com
Public Enquiries
Title Dr 
Last name Jenkins 
First name Aaron 
Address line 1Walton Oaks, Dorking Road 
Address line 2 
Address line 3 
CityTadworth, Surrey 
PostcodeKT20 7NS 
CountryUnited Kingdom 
Phone number (incl. country code)441737330722 
Alternative phone number 
Fax number (incl. country code) 
Email address Aaron.Jenkins@pfizer.com 
Top